Skip to main content

Table 3 Cumulative Dose-Related Reduction in Fracture Risk Achieved by Steroid-Dependent Asthmatic Adults after Substituting ICS for Past Prednisone Therapy

From: Asthma and Therapeutics: Inhaled Corticosteroids, Corticosteroid Osteoporosis, and the Risk of Fracture in Chronic Asthma

 

Percent of Group with Normal Bone Density*

 

Cumulative Lifetime ICS Exposure

Men (n = 26)

Women (n = 43) †

(10.1 ± 5.5 yr)

Age 58.5 ± 17.6 (SD) yr

Age 60.8 ± 9.6 (SD) yr

≤3 g‡

20

50

>3 g‡

40§

65§

  1. Adapted from Toogood JH et al. [4]
  2. ICS = inhaled corticosteroid.
  3. *Lumbosacral bone mineral density Z-score (LBMD-Z): +4 to -1.
  4. †All postmenopausal women received supplemental estrogen.
  5. ‡Median lifetime cumulative ICS exposure = 3 g. Lifetime prednisone exposures were balanced equally between the higher and lower lifetime ICS exposure subgroups (p = .87) [4].
  6. §Larger lifetime exposures to ICS were associated with more normal LBMD-Z scores (p = .002 analysis of covariance) and a substantially larger number of patients with Z-scores indicating no increase in fracture risk [4].